Imipenem and Cilastatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Imipenem and Cilastatin Injection (injection) from Merck Sharp & Dohme Corp. with status To Be Discontinued. The shortage was first posted on Jan 8, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Merck Sharp & Dohme Corp.
- Package NDC
- 0006-3516-59
- Dosage Form
- Injection
- Presentation
- Primaxin, Injection, 500mg (NDC 0006-3516-59)
- Initial Posting
- Jan 8, 2026